ID   CATC_HUMAN              Reviewed;         463 AA.
AC   P53634; A8K7V2; B5MDD5; Q2HIY8; Q53G93; Q71E75; Q71E76; Q7M4N9;
AC   Q7Z3G7; Q7Z5U7; Q8WY99; Q8WYA7; Q8WYA8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   10-MAY-2017, entry version 182.
DE   RecName: Full=Dipeptidyl peptidase 1;
DE            EC=3.4.14.1;
DE   AltName: Full=Cathepsin C;
DE   AltName: Full=Cathepsin J;
DE   AltName: Full=Dipeptidyl peptidase I;
DE            Short=DPP-I;
DE            Short=DPPI;
DE   AltName: Full=Dipeptidyl transferase;
DE   Contains:
DE     RecName: Full=Dipeptidyl peptidase 1 exclusion domain chain;
DE     AltName: Full=Dipeptidyl peptidase I exclusion domain chain;
DE   Contains:
DE     RecName: Full=Dipeptidyl peptidase 1 heavy chain;
DE     AltName: Full=Dipeptidyl peptidase I heavy chain;
DE   Contains:
DE     RecName: Full=Dipeptidyl peptidase 1 light chain;
DE     AltName: Full=Dipeptidyl peptidase I light chain;
DE   Flags: Precursor;
GN   Name=CTSC; Synonyms=CPPI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-153.
RC   TISSUE=Ileum;
RX   PubMed=7649281; DOI=10.1016/0014-5793(95)00777-7;
RA   Paris A., Strukelj B., Pungercar J., Renko M., Dolenc I., Turk V.;
RT   "Molecular cloning and sequence analysis of human preprocathepsin C.";
RL   FEBS Lett. 369:326-330(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], INDUCTION, TISSUE SPECIFICITY, AND
RP   VARIANT THR-153.
RX   PubMed=9092576; DOI=10.1074/jbc.272.15.10260;
RA   Rao N.V., Rao G.V., Hoidal J.R.;
RT   "Human dipeptidyl-peptidase I. Gene characterization, localization,
RT   and expression.";
RL   J. Biol. Chem. 272:10260-10265(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS PLS TYR-236; ARG-286
RP   AND TYR-291, AND VARIANT THR-153.
RC   TISSUE=Blood;
RX   PubMed=11180601;
RX   DOI=10.1002/1098-1004(200102)17:2<152::AID-HUMU10>3.3.CO;2-R;
RA   Allende L.M., Garcia-Perez M.A., Moreno A., Corell A., Carasol M.,
RA   Martinez-Canut P., Arnaiz-Villena A.;
RT   "Cathepsin C gene: first compound heterozygous patient with Papillon-
RT   Lefevre syndrome and a novel symptomless mutation.";
RL   Hum. Mutat. 17:152-153(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS THR-153 AND PLS
RP   HIS-294.
RC   TISSUE=Blood;
RX   PubMed=12809647; DOI=10.1016/S1096-7192(03)00070-2;
RA   Allende L.M., Moreno A., de Unamuno P.;
RT   "A genetic study of cathepsin C gene in two families with Papillon-
RT   Lefevre syndrome.";
RL   Mol. Genet. Metab. 79:146-148(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   THR-153.
RC   TISSUE=Cerebellum, and Rheumatoid arthritic synovial fluid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   THR-153.
RC   TISSUE=Thyroid;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT THR-153.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 25-71; 122-143; 231-235 AND 395-399,
RP   CHARACTERIZATION OF EXCLUSION DOMAIN, AND GLYCOSYLATION.
RX   PubMed=9507095; DOI=10.1016/S0167-4838(97)00173-8;
RA   Cigic B., Krizaj I., Kralj B., Turk V., Pain R.H.;
RT   "Stoichiometry and heterogeneity of the pro-region chain in tetrameric
RT   human cathepsin C.";
RL   Biochim. Biophys. Acta 1382:143-150(1998).
RN   [12]
RP   PROTEIN SEQUENCE OF 25-34; 231-239 AND 395-404, AND CHARACTERIZATION.
RX   PubMed=7665576; DOI=10.1074/jbc.270.37.21626;
RA   Dolenc I., Turk B., Pungercic G., Ritonja A., Turk V.;
RT   "Oligomeric structure and substrate induced inhibition of human
RT   cathepsin C.";
RL   J. Biol. Chem. 270:21626-21631(1995).
RN   [13]
RP   PROTEIN SEQUENCE OF 25-28; 51-61; 114-117 AND 133-139,
RP   CHARACTERIZATION OF EXCLUSION DOMAIN, AND DISULFIDE BONDS.
RX   PubMed=11015218; DOI=10.1021/bi0008837;
RA   Cigic B., Dahl S.W., Pain R.H.;
RT   "The residual pro-part of cathepsin C fulfills the criteria required
RT   for an intramolecular chaperone in folding and stabilizing the human
RT   proenzyme.";
RL   Biochemistry 39:12382-12390(2000).
RN   [14]
RP   PROTEIN SEQUENCE OF 231-290; 310-328 AND 340-383, FUNCTION, ENZYME
RP   REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, GLYCOSYLATION, AND
RP   VARIANT THR-153.
RC   TISSUE=Spleen;
RX   PubMed=1586157; DOI=10.1016/0003-9861(92)90519-3;
RA   McGuire M.J., Lipsky P.E., Thiele D.L.;
RT   "Purification and characterization of dipeptidyl peptidase I from
RT   human spleen.";
RL   Arch. Biochem. Biophys. 295:280-288(1992).
RN   [15]
RP   GLYCOSYLATION AT ASN-29; ASN-53; ASN-119 AND ASN-276.
RX   PubMed=19167329; DOI=10.1016/j.cell.2008.11.047;
RA   Ruiz-Canada C., Kelleher D.J., Gilmore R.;
RT   "Cotranslational and posttranslational N-glycosylation of polypeptides
RT   by distinct mammalian OST isoforms.";
RL   Cell 136:272-283(2009).
RN   [16]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-53.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 25-143 AND 231-463 IN
RP   COMPLEX WITH CHLORIDE IONS, SUBUNIT, DISULFIDE BONDS, AND
RP   GLYCOSYLATION AT ASN-29.
RX   PubMed=11726493; DOI=10.1093/emboj/20.23.6570;
RA   Turk D., Janjic V., Stern I., Podobnik M., Lamba D., Dahl S.W.,
RA   Lauritzen C., Pedersen J., Turk V., Turk B.;
RT   "Structure of human dipeptidyl peptidase I (cathepsin C): exclusion
RT   domain added to an endopeptidase framework creates the machine for
RT   activation of granular serine proteases.";
RL   EMBO J. 20:6570-6582(2001).
RN   [21]
RP   VARIANTS PLS PHE-249; LEU-252; PRO-272; SER-301; CYS-339 AND CYS-347.
RX   PubMed=10581027; DOI=10.1038/70525;
RA   Toomes C., James J., Wood A.J., Wu C.L., McCormick D., Lench N.,
RA   Hewitt C., Moynihan L., Roberts E., Woods C.G., Markham A., Wong M.,
RA   Widmer R., Ghaffar K.A., Pemberton M., Hussein I.R., Temtamy S.A.,
RA   Davies R., Read A.P., Sloan P., Dixon M.J., Thakker N.S.;
RT   "Loss-of-function mutations in the cathepsin C gene result in
RT   periodontal disease and palmoplantar keratosis.";
RL   Nat. Genet. 23:421-424(1999).
RN   [22]
RP   VARIANT HMS ARG-286.
RX   PubMed=10662807; DOI=10.1136/jmg.37.2.88;
RA   Hart T.C., Hart P.S., Michalec M.D., Zhang Y., Firatli E.,
RA   Van Dyke T.E., Stabholz A., Zlotogorski A., Shapira L., Soskolne W.A.;
RT   "Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic
RT   mutations in cathepsin C.";
RL   J. Med. Genet. 37:88-94(2000).
RN   [23]
RP   VARIANTS PLS CYS-339 AND CYS-340, AND VARIANT AP1 CYS-347.
RX   PubMed=10662808; DOI=10.1136/jmg.37.2.95;
RA   Hart T.C., Hart P.S., Michalec M.D., Zhang Y., Marazita M.L.,
RA   Cooper M., Yassin O.M., Nusier M., Walker S.;
RT   "Localisation of a gene for prepubertal periodontitis to chromosome
RT   11q14 and identification of a cathepsin C gene mutation.";
RL   J. Med. Genet. 37:95-101(2000).
RN   [24]
RP   VARIANTS PLS 67-TYR--ALA-74 DEL; PRO-272; SER-300; VAL-301; SER-301;
RP   ASN-304; GLY-319; CYS-339; CYS-340 AND GLY-447, AND VARIANT THR-153.
RX   PubMed=11106356; DOI=10.1136/jmg.37.12.927;
RA   Hart P.S., Zhang Y., Firatli E., Uygur C., Lotfazar M., Michalec M.D.,
RA   Marks J.J., Lu X., Coates B.J., Seow W.K., Marshall R., Williams D.,
RA   Reed J.B., Wright J.T., Hart T.C.;
RT   "Identification of cathepsin C mutations in ethnically diverse
RT   Papillon-Lefevre syndrome patients.";
RL   J. Med. Genet. 37:927-932(2000).
RN   [25]
RP   VARIANTS PLS SER-39 AND SER-301, AND VARIANT VAL-453.
RX   PubMed=11180012; DOI=10.1046/j.1523-1747.2001.01244.x;
RA   Nakano A., Nomura K., Nakano H., Ono Y., LaForgia S., Pulkkinen L.,
RA   Hashimoto I., Uitto J.;
RT   "Papillon-Lefevre syndrome: mutations and polymorphisms in the
RT   cathepsin C gene.";
RL   J. Invest. Dermatol. 116:339-343(2001).
RN   [26]
RP   VARIANTS PLS PRO-127; PRO-272; CYS-339 AND CYS-429, AND VARIANTS
RP   THR-153 AND LYS-401.
RX   PubMed=11886537; DOI=10.1046/j.0022-202x.2001.01595.x;
RA   Lefevre C., Blanchet-Bardon C., Jobard F., Bouadjar B., Stalder J.-F.,
RA   Cure S., Hoffmann A., Prud'Homme J.-F., Fischer J.;
RT   "Novel point mutations, deletions, and polymorphisms in the cathepsin
RT   C gene in nine families from Europe and North Africa with Papillon-
RT   Lefevre syndrome.";
RL   J. Invest. Dermatol. 117:1657-1661(2001).
RN   [27]
RP   VARIANTS PLS PRO-272 AND ASP-300.
RX   PubMed=11158173; DOI=10.1136/jmg.38.2.96;
RA   Zhang Y., Lundgren T., Renvert S., Tatakis D.N., Firatli E., Uygur C.,
RA   Hart P.S., Gorry M.C., Marks J.J., Hart T.C.;
RT   "Evidence of a founder effect for four cathepsin C gene mutations in
RT   Papillon-Lefevre syndrome patients.";
RL   J. Med. Genet. 38:96-101(2001).
RN   [28]
RP   VARIANTS PLS ARG-139 AND PRO-272, AND VARIANT THR-153.
RX   PubMed=12112662; DOI=10.1002/humu.9040;
RA   Zhang Y., Hart P.S., Moretti A.J., Bouwsma O.J., Fisher E.M.,
RA   Dudlicek L., Pettenati M.J., Hart T.C.;
RT   "Biochemical and mutational analyses of the cathepsin c gene (CTSC) in
RT   three North American families with Papillon Lefevre syndrome.";
RL   Hum. Mutat. 20:75-75(2002).
RN   [29]
RP   VARIANTS PLS GLU-129; ARG-139; TYR-236; PHE-249; LEU-252; HIS-272;
RP   SER-301; ARG-312; CYS-339; CYS-347 AND GLY-447, VARIANTS AP1 HIS-272
RP   AND CYS-412, AND VARIANT THR-153.
RX   PubMed=14974080; DOI=10.1002/humu.10314;
RA   Hewitt C., McCormick D., Linden G., Turk D., Stern I., Wallace I.,
RA   Southern L., Zhang L., Howard R., Bullon P., Wong M., Widmer R.,
RA   Gaffar K.A., Awawdeh L., Briggs J., Yaghmai R., Jabs E.W., Hoeger P.,
RA   Bleck O., Rudiger S.G., Petersilka G., Battino M., Brett P.,
RA   Hattab F., Al-Hamed M., Sloan P., Toomes C., Dixon M.J., James J.,
RA   Read A.P., Thakker N.S.;
RT   "The role of cathepsin C in Papillon-Lefevre syndrome, prepubertal
RT   periodontitis, and aggressive periodontitis.";
RL   Hum. Mutat. 23:222-228(2004).
RN   [30]
RP   VARIANT PLS ASN-405.
RX   PubMed=15108292; DOI=10.1002/humu.9243;
RA   de Haar S.F., Jansen D.C., Schoenmaker T., De Vree H., Everts V.,
RA   Beertsen W.;
RT   "Loss-of-function mutations in cathepsin C in two families with
RT   Papillon-Lefevre syndrome are associated with deficiency of serine
RT   proteinases in PMNs.";
RL   Hum. Mutat. 23:524-524(2004).
RN   [31]
RP   VARIANT PLS ARG-405.
RX   PubMed=15991336;
RA   de Haar S.F., Mir M., Nguyen M., Kazemi B., Ramezani G.H., Everts V.;
RT   "Gene symbol: CTSC. Disease: Papillon-Lefevre syndrome.";
RL   Hum. Genet. 116:545-545(2005).
RN   [32]
RP   ERRATUM.
RA   de Haar S.F., Mir M., Nguyen M., Kazemi B., Ramezani G.H., Everts V.;
RL   Hum. Genet. 118:533-533(2005).
RN   [33]
RP   VARIANT PLS ASP-300.
RX   PubMed=25799584; DOI=10.1371/journal.pone.0121351;
RA   Erzurumluoglu A.M., Alsaadi M.M., Rodriguez S., Alotaibi T.S.,
RA   Guthrie P.A., Lewis S., Ginwalla A., Gaunt T.R., Alharbi K.K.,
RA   Alsaif F.M., Alsaadi B.M., Day I.N.;
RT   "Proxy molecular diagnosis from whole-exome sequencing reveals
RT   Papillon-Lefevre syndrome caused by a missense mutation in CTSC.";
RL   PLoS ONE 10:E0121351-E0121351(2015).
CC   -!- FUNCTION: Thiol protease. Has dipeptidylpeptidase activity. Active
CC       against a broad range of dipeptide substrates composed of both
CC       polar and hydrophobic amino acids. Proline cannot occupy the P1
CC       position and arginine cannot occupy the P2 position of the
CC       substrate. Can act as both an exopeptidase and endopeptidase.
CC       Activates serine proteases such as elastase, cathepsin G and
CC       granzymes A and B. Can also activate neuraminidase and factor
CC       XIII. {ECO:0000269|PubMed:1586157}.
CC   -!- CATALYTIC ACTIVITY: Release of an N-terminal dipeptide, Xaa-Yaa-|-
CC       Zaa-, except when Xaa is Arg or Lys, or Yaa or Zaa is Pro.
CC   -!- COFACTOR:
CC       Name=chloride; Xref=ChEBI:CHEBI:17996;
CC       Note=Binds 1 Cl(-) ion per heavy chain.;
CC   -!- ENZYME REGULATION: Strongly inhibited by the cysteine peptidase
CC       inhibitors mersalyl acid, iodoacetic acid and cystatin. Inhibited
CC       by N-ethylmaleimide, Gly-Phe-diazomethane, TLCK, TPCK and, at low
CC       pH, by dithiodipyridine. Not inhibited by the serine peptidase
CC       inhibitor PMSF, the aminopeptidase inhibitor bestatin, or metal
CC       ion chelators. {ECO:0000269|PubMed:1586157}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         High activity at pH 4.5-6.8. {ECO:0000269|PubMed:1586157};
CC   -!- SUBUNIT: Tetramer of heterotrimers consisting of exclusion domain,
CC       heavy- and light chains. {ECO:0000269|PubMed:11726493,
CC       ECO:0000269|PubMed:1586157}.
CC   -!- INTERACTION:
CC       O76096:CST7; NbExp=2; IntAct=EBI-1047323, EBI-2807448;
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P53634-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P53634-2; Sequence=VSP_039123, VSP_039124;
CC       Name=3;
CC         IsoId=P53634-3; Sequence=VSP_043232, VSP_043233;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in lung, kidney
CC       and placenta. Detected at intermediate levels in colon, small
CC       intestine, spleen and pancreas. {ECO:0000269|PubMed:9092576}.
CC   -!- INDUCTION: Up-regulated in lymphocytes by IL2/interleukin-2.
CC       {ECO:0000269|PubMed:9092576}.
CC   -!- PTM: N-glycosylated. While glycosylation at Asn-53, Asn-119 and
CC       Asn-276 is mediated by STT3A-containing complexes, glycosylation
CC       at Asn-29 is mediated STT3B-containing complexes.
CC       {ECO:0000269|PubMed:11726493, ECO:0000269|PubMed:1586157,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19167329,
CC       ECO:0000269|PubMed:9507095}.
CC   -!- PTM: In approximately 50% of the complexes the exclusion domain is
CC       cleaved at position 58 or 61. The two parts of the exclusion
CC       domain are held together by a disulfide bond.
CC   -!- DISEASE: Papillon-Lefevre syndrome (PLS) [MIM:245000]: An
CC       autosomal recessive disorder characterized by palmoplantar
CC       keratosis and severe periodontitis affecting deciduous and
CC       permanent dentitions and resulting in premature tooth loss. The
CC       palmoplantar keratotic phenotype vary from mild psoriasiform scaly
CC       skin to overt hyperkeratosis. Keratosis also affects other sites
CC       such as elbows and knees. {ECO:0000269|PubMed:10581027,
CC       ECO:0000269|PubMed:10662808, ECO:0000269|PubMed:11106356,
CC       ECO:0000269|PubMed:11158173, ECO:0000269|PubMed:11180012,
CC       ECO:0000269|PubMed:11180601, ECO:0000269|PubMed:11886537,
CC       ECO:0000269|PubMed:12112662, ECO:0000269|PubMed:12809647,
CC       ECO:0000269|PubMed:14974080, ECO:0000269|PubMed:15108292,
CC       ECO:0000269|PubMed:15991336, ECO:0000269|PubMed:25799584}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Haim-Munk syndrome (HMS) [MIM:245010]: An autosomal
CC       recessive disorder characterized by palmoplantar keratosis,
CC       onychogryphosis and periodontitis. Additional features are pes
CC       planus, arachnodactyly, and acroosteolysis.
CC       {ECO:0000269|PubMed:10662807}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Periodontititis, aggressive, 1 (AP1) [MIM:170650]: A
CC       disease characterized by severe and protracted gingival
CC       infections, generalized or localized, leading to tooth loss.
CC       Amounts of microbial deposits are generally inconsistent with the
CC       severity of periodontal tissue destruction and the progression of
CC       attachment and bone loss may be self arresting.
CC       {ECO:0000269|PubMed:10662808, ECO:0000269|PubMed:14974080}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD97897.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=CTSCbase; Note=CTSC mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/CTSCbase/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X87212; CAA60671.1; -; mRNA.
DR   EMBL; U79415; AAC51341.1; -; Genomic_DNA.
DR   EMBL; AF234263; AAL48191.1; -; mRNA.
DR   EMBL; AF234264; AAL48192.1; -; mRNA.
DR   EMBL; AF254757; AAL48195.1; -; mRNA.
DR   EMBL; AF525032; AAQ08887.1; -; mRNA.
DR   EMBL; AF525033; AAQ08888.1; -; mRNA.
DR   EMBL; AK292117; BAF84806.1; -; mRNA.
DR   EMBL; AK311923; BAG34864.1; -; mRNA.
DR   EMBL; AK223038; BAD96758.1; -; mRNA.
DR   EMBL; BX537913; CAD97897.1; ALT_INIT; mRNA.
DR   EMBL; AC011088; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471185; EAW59364.1; -; Genomic_DNA.
DR   EMBL; BC054028; AAH54028.1; -; mRNA.
DR   EMBL; BC100891; AAI00892.1; -; mRNA.
DR   EMBL; BC100892; AAI00893.1; -; mRNA.
DR   EMBL; BC100893; AAI00894.1; -; mRNA.
DR   EMBL; BC100894; AAI00895.1; -; mRNA.
DR   EMBL; BC109386; AAI09387.1; -; mRNA.
DR   EMBL; BC110071; AAI10072.1; -; mRNA.
DR   EMBL; BC113850; AAI13851.1; -; mRNA.
DR   EMBL; BC113897; AAI13898.1; -; mRNA.
DR   CCDS; CCDS31654.1; -. [P53634-2]
DR   CCDS; CCDS44693.1; -. [P53634-3]
DR   CCDS; CCDS8282.1; -. [P53634-1]
DR   PIR; S23941; S23941.
DR   PIR; S66504; S66504.
DR   RefSeq; NP_001107645.1; NM_001114173.2. [P53634-3]
DR   RefSeq; NP_001805.3; NM_001814.5.
DR   RefSeq; NP_680475.1; NM_148170.4. [P53634-2]
DR   UniGene; Hs.128065; -.
DR   PDB; 1K3B; X-ray; 2.15 A; A=25-143, B=231-394, C=395-463.
DR   PDB; 2DJF; X-ray; 2.00 A; A=25-143, B=231-394, C=395-463.
DR   PDB; 2DJG; X-ray; 2.05 A; A=25-143, B=231-394, C=395-463.
DR   PDB; 3PDF; X-ray; 1.85 A; A=25-463.
DR   PDB; 4CDC; X-ray; 2.40 A; A/D/G/J=25-143, B/E/H/K=230-394, C/F/I/L=395-463.
DR   PDB; 4CDD; X-ray; 2.35 A; A/D=25-144, B/E=230-394, C/F=395-463.
DR   PDB; 4CDE; X-ray; 2.40 A; A/D=25-143, B/E=230-394, C/F=395-463.
DR   PDB; 4CDF; X-ray; 2.20 A; A/D=25-144, B/E=229-394, C/F=395-463.
DR   PDB; 4OEL; X-ray; 1.40 A; A=25-394, B=395-463.
DR   PDB; 4OEM; X-ray; 1.52 A; A=25-394, B=395-463.
DR   PDBsum; 1K3B; -.
DR   PDBsum; 2DJF; -.
DR   PDBsum; 2DJG; -.
DR   PDBsum; 3PDF; -.
DR   PDBsum; 4CDC; -.
DR   PDBsum; 4CDD; -.
DR   PDBsum; 4CDE; -.
DR   PDBsum; 4CDF; -.
DR   PDBsum; 4OEL; -.
DR   PDBsum; 4OEM; -.
DR   ProteinModelPortal; P53634; -.
DR   SMR; P53634; -.
DR   BioGrid; 107502; 24.
DR   IntAct; P53634; 22.
DR   MINT; MINT-4655964; -.
DR   STRING; 9606.ENSP00000227266; -.
DR   BindingDB; P53634; -.
DR   ChEMBL; CHEMBL2252; -.
DR   GuidetoPHARMACOLOGY; 2344; -.
DR   MEROPS; C01.070; -.
DR   iPTMnet; P53634; -.
DR   PhosphoSitePlus; P53634; -.
DR   SwissPalm; P53634; -.
DR   BioMuta; CTSC; -.
DR   DMDM; 317373330; -.
DR   EPD; P53634; -.
DR   MaxQB; P53634; -.
DR   PaxDb; P53634; -.
DR   PeptideAtlas; P53634; -.
DR   PRIDE; P53634; -.
DR   TopDownProteomics; P53634-1; -. [P53634-1]
DR   DNASU; 1075; -.
DR   Ensembl; ENST00000227266; ENSP00000227266; ENSG00000109861. [P53634-1]
DR   Ensembl; ENST00000524463; ENSP00000432541; ENSG00000109861. [P53634-2]
DR   Ensembl; ENST00000529974; ENSP00000433539; ENSG00000109861. [P53634-3]
DR   GeneID; 1075; -.
DR   KEGG; hsa:1075; -.
DR   UCSC; uc001pck.5; human. [P53634-1]
DR   CTD; 1075; -.
DR   DisGeNET; 1075; -.
DR   GeneCards; CTSC; -.
DR   HGNC; HGNC:2528; CTSC.
DR   HPA; CAB025364; -.
DR   HPA; HPA066610; -.
DR   HPA; HPA068434; -.
DR   MalaCards; CTSC; -.
DR   MIM; 170650; phenotype.
DR   MIM; 245000; phenotype.
DR   MIM; 245010; phenotype.
DR   MIM; 602365; gene.
DR   neXtProt; NX_P53634; -.
DR   OpenTargets; ENSG00000109861; -.
DR   Orphanet; 2342; Haim-Munk syndrome.
DR   Orphanet; 678; Papillon-Lefevre syndrome.
DR   PharmGKB; PA27028; -.
DR   eggNOG; KOG1543; Eukaryota.
DR   eggNOG; COG4870; LUCA.
DR   GeneTree; ENSGT00760000118871; -.
DR   HOGENOM; HOG000127503; -.
DR   HOVERGEN; HBG005248; -.
DR   InParanoid; P53634; -.
DR   KO; K01275; -.
DR   OMA; YDDFLHY; -.
DR   OrthoDB; EOG091G06TT; -.
DR   PhylomeDB; P53634; -.
DR   TreeFam; TF313225; -.
DR   BioCyc; MetaCyc:HS03265-MONOMER; -.
DR   BRENDA; 3.4.14.1; 2681.
DR   Reactome; R-HSA-204005; COPII (Coat Protein 2) Mediated Vesicle Transport.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-5694530; Cargo concentration in the ER.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SABIO-RK; P53634; -.
DR   ChiTaRS; CTSC; human.
DR   EvolutionaryTrace; P53634; -.
DR   GeneWiki; Cathepsin_C; -.
DR   GenomeRNAi; 1075; -.
DR   PMAP-CutDB; P53634; -.
DR   PRO; PR:P53634; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000109861; -.
DR   ExpressionAtlas; P53634; baseline and differential.
DR   Genevisible; P53634; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; TAS:Reactome.
DR   GO; GO:0030134; C:ER to Golgi transport vesicle; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005764; C:lysosome; ISS:BHF-UCL.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0051087; F:chaperone binding; ISS:BHF-UCL.
DR   GO; GO:0031404; F:chloride ion binding; IEA:Ensembl.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0016505; F:peptidase activator activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0019902; F:phosphatase binding; ISS:BHF-UCL.
DR   GO; GO:0043621; F:protein self-association; IEA:Ensembl.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0048208; P:COPII vesicle coating; TAS:Reactome.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:1903052; P:positive regulation of proteolysis involved in cellular protein catabolic process; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IBA:GO_Central.
DR   GO; GO:0010033; P:response to organic substance; IEA:Ensembl.
DR   GO; GO:0001913; P:T cell mediated cytotoxicity; IEA:Ensembl.
DR   Gene3D; 2.40.128.80; -; 1.
DR   InterPro; IPR014882; CathepsinC_exc.
DR   InterPro; IPR033161; DPP_I.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   PANTHER; PTHR12411:SF448; PTHR12411:SF448; 1.
DR   Pfam; PF08773; CathepsinC_exc; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00645; Pept_C1; 1.
DR   SUPFAM; SSF75001; SSF75001; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chloride; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Hydrolase; Lysosome; Palmoplantar keratoderma;
KW   Polymorphism; Protease; Reference proteome; Signal; Thiol protease;
KW   Zymogen.
FT   SIGNAL        1     24       {ECO:0000269|PubMed:11015218,
FT                                ECO:0000269|PubMed:7665576,
FT                                ECO:0000269|PubMed:9507095}.
FT   CHAIN        25    134       Dipeptidyl peptidase 1 exclusion domain
FT                                chain.
FT                                /FTId=PRO_0000026338.
FT   PROPEP      135    230       {ECO:0000269|PubMed:1586157,
FT                                ECO:0000269|PubMed:7665576,
FT                                ECO:0000269|PubMed:9507095}.
FT                                /FTId=PRO_0000026339.
FT   CHAIN       231    394       Dipeptidyl peptidase 1 heavy chain.
FT                                /FTId=PRO_0000026340.
FT   CHAIN       395    463       Dipeptidyl peptidase 1 light chain.
FT                                /FTId=PRO_0000026341.
FT   ACT_SITE    258    258
FT   ACT_SITE    405    405
FT   ACT_SITE    427    427
FT   BINDING     302    302       Chloride.
FT   BINDING     304    304       Chloride; via amide nitrogen.
FT   BINDING     347    347       Chloride.
FT   CARBOHYD     29     29       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:11726493,
FT                                ECO:0000269|PubMed:19167329}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19167329}.
FT   CARBOHYD    119    119       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19167329}.
FT   CARBOHYD    276    276       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19167329}.
FT   DISULFID     30    118
FT   DISULFID     54    136
FT   DISULFID    255    298
FT   DISULFID    291    331
FT   DISULFID    321    337
FT   VAR_SEQ     107    141       YKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKK -> DV
FT                                TDFISHLFMQLGTVGIYDLPHLRNKLAMNRRWG (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043232.
FT   VAR_SEQ     107    137       YKEEGSKVTTYCNETMTGWVHDVLGRNWACF -> DVTDFI
FT                                SHLFMQLGTVGIYDLPHLRNKLVIK (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_039123.
FT   VAR_SEQ     138    463       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_039124.
FT   VAR_SEQ     142    463       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043233.
FT   VARIANT      39     39       W -> S (in PLS; dbSNP:rs104894210).
FT                                {ECO:0000269|PubMed:11180012}.
FT                                /FTId=VAR_016933.
FT   VARIANT      67     74       Missing (in PLS).
FT                                {ECO:0000269|PubMed:11106356}.
FT                                /FTId=VAR_019035.
FT   VARIANT     127    127       H -> P (in PLS; dbSNP:rs104894216).
FT                                {ECO:0000269|PubMed:11886537}.
FT                                /FTId=VAR_016934.
FT   VARIANT     129    129       V -> E (in PLS; dbSNP:rs760130711).
FT                                {ECO:0000269|PubMed:14974080}.
FT                                /FTId=VAR_019036.
FT   VARIANT     139    139       G -> R (in PLS; dbSNP:rs749103588).
FT                                {ECO:0000269|PubMed:12112662,
FT                                ECO:0000269|PubMed:14974080}.
FT                                /FTId=VAR_019037.
FT   VARIANT     153    153       I -> T (in dbSNP:rs217086).
FT                                {ECO:0000269|PubMed:11106356,
FT                                ECO:0000269|PubMed:11180601,
FT                                ECO:0000269|PubMed:11886537,
FT                                ECO:0000269|PubMed:12112662,
FT                                ECO:0000269|PubMed:12809647,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:14974080,
FT                                ECO:0000269|PubMed:1586157,
FT                                ECO:0000269|PubMed:7649281,
FT                                ECO:0000269|PubMed:9092576,
FT                                ECO:0000269|Ref.6, ECO:0000269|Ref.9}.
FT                                /FTId=VAR_016943.
FT   VARIANT     236    236       D -> Y (in PLS; dbSNP:rs764724707).
FT                                {ECO:0000269|PubMed:11180601,
FT                                ECO:0000269|PubMed:14974080}.
FT                                /FTId=VAR_019038.
FT   VARIANT     249    249       V -> F (in PLS).
FT                                {ECO:0000269|PubMed:10581027,
FT                                ECO:0000269|PubMed:14974080}.
FT                                /FTId=VAR_009541.
FT   VARIANT     252    252       Q -> L (in PLS; dbSNP:rs104894207).
FT                                {ECO:0000269|PubMed:10581027,
FT                                ECO:0000269|PubMed:14974080}.
FT                                /FTId=VAR_009542.
FT   VARIANT     272    272       R -> H (in PLS; dbSNP:rs587777534).
FT                                {ECO:0000269|PubMed:14974080}.
FT                                /FTId=VAR_019039.
FT   VARIANT     272    272       R -> P (in PLS; dbSNP:rs587777534).
FT                                {ECO:0000269|PubMed:10581027,
FT                                ECO:0000269|PubMed:11106356,
FT                                ECO:0000269|PubMed:11158173,
FT                                ECO:0000269|PubMed:11886537,
FT                                ECO:0000269|PubMed:12112662}.
FT                                /FTId=VAR_009543.
FT   VARIANT     286    286       Q -> R (in HMS and PLS;
FT                                dbSNP:rs104894208).
FT                                {ECO:0000269|PubMed:10662807,
FT                                ECO:0000269|PubMed:11180601}.
FT                                /FTId=VAR_016935.
FT   VARIANT     291    291       C -> Y (in PLS; dbSNP:rs748729285).
FT                                {ECO:0000269|PubMed:11180601}.
FT                                /FTId=VAR_019040.
FT   VARIANT     294    294       Y -> H (in PLS).
FT                                {ECO:0000269|PubMed:12809647}.
FT                                /FTId=VAR_039686.
FT   VARIANT     300    300       G -> D (in PLS).
FT                                {ECO:0000269|PubMed:11158173,
FT                                ECO:0000269|PubMed:25799584}.
FT                                /FTId=VAR_019041.
FT   VARIANT     300    300       G -> S (in PLS).
FT                                {ECO:0000269|PubMed:11106356}.
FT                                /FTId=VAR_019042.
FT   VARIANT     301    301       G -> S (in PLS; dbSNP:rs104894214).
FT                                {ECO:0000269|PubMed:10581027,
FT                                ECO:0000269|PubMed:11106356,
FT                                ECO:0000269|PubMed:11180012,
FT                                ECO:0000269|PubMed:14974080}.
FT                                /FTId=VAR_009544.
FT   VARIANT     301    301       G -> V (in PLS).
FT                                {ECO:0000269|PubMed:11106356}.
FT                                /FTId=VAR_019043.
FT   VARIANT     304    304       Y -> N (in PLS).
FT                                {ECO:0000269|PubMed:11106356}.
FT                                /FTId=VAR_019044.
FT   VARIANT     312    312       Q -> R (in PLS).
FT                                {ECO:0000269|PubMed:14974080}.
FT                                /FTId=VAR_019045.
FT   VARIANT     319    319       E -> G (in PLS).
FT                                {ECO:0000269|PubMed:11106356}.
FT                                /FTId=VAR_019046.
FT   VARIANT     339    339       R -> C (in PLS).
FT                                {ECO:0000269|PubMed:10581027,
FT                                ECO:0000269|PubMed:10662808,
FT                                ECO:0000269|PubMed:11106356,
FT                                ECO:0000269|PubMed:11886537,
FT                                ECO:0000269|PubMed:14974080}.
FT                                /FTId=VAR_009545.
FT   VARIANT     340    340       Y -> C (in PLS).
FT                                {ECO:0000269|PubMed:10662808,
FT                                ECO:0000269|PubMed:11106356}.
FT                                /FTId=VAR_016944.
FT   VARIANT     347    347       Y -> C (in PLS and AP1;
FT                                dbSNP:rs104894211).
FT                                {ECO:0000269|PubMed:10581027,
FT                                ECO:0000269|PubMed:10662808,
FT                                ECO:0000269|PubMed:14974080}.
FT                                /FTId=VAR_009546.
FT   VARIANT     401    401       E -> K (in dbSNP:rs200627023).
FT                                {ECO:0000269|PubMed:11886537}.
FT                                /FTId=VAR_016945.
FT   VARIANT     405    405       H -> N (in PLS).
FT                                {ECO:0000269|PubMed:15108292}.
FT                                /FTId=VAR_027249.
FT   VARIANT     405    405       H -> R (in PLS; dbSNP:rs151269219).
FT                                {ECO:0000269|PubMed:15991336}.
FT                                /FTId=VAR_027250.
FT   VARIANT     412    412       Y -> C (in AP1; dbSNP:rs28937571).
FT                                {ECO:0000269|PubMed:14974080}.
FT                                /FTId=VAR_019047.
FT   VARIANT     429    429       W -> C (in PLS; dbSNP:rs104894215).
FT                                {ECO:0000269|PubMed:11886537}.
FT                                /FTId=VAR_016936.
FT   VARIANT     447    447       E -> G (in PLS).
FT                                {ECO:0000269|PubMed:11106356,
FT                                ECO:0000269|PubMed:14974080}.
FT                                /FTId=VAR_019048.
FT   VARIANT     453    453       I -> V (rare polymorphism;
FT                                dbSNP:rs3888798).
FT                                {ECO:0000269|PubMed:11180012}.
FT                                /FTId=VAR_016946.
FT   CONFLICT     63     63       K -> I (in Ref. 6; BAD96758).
FT                                {ECO:0000305}.
FT   CONFLICT    237    237       W -> V (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    321    321       C -> S (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    355    355       C -> M (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    366    366       H -> R (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    376    378       VYD -> YVY (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX        32     35       {ECO:0000244|PDB:4OEL}.
FT   STRAND       37     48       {ECO:0000244|PDB:4OEL}.
FT   TURN         49     51       {ECO:0000244|PDB:1K3B}.
FT   HELIX        54     56       {ECO:0000244|PDB:4OEL}.
FT   STRAND       60     69       {ECO:0000244|PDB:4OEL}.
FT   TURN         70     72       {ECO:0000244|PDB:4OEL}.
FT   STRAND       73     75       {ECO:0000244|PDB:4OEL}.
FT   STRAND       81     87       {ECO:0000244|PDB:4OEL}.
FT   TURN         88     90       {ECO:0000244|PDB:4OEL}.
FT   STRAND       91     96       {ECO:0000244|PDB:4OEL}.
FT   STRAND       99    110       {ECO:0000244|PDB:4OEL}.
FT   STRAND      113    121       {ECO:0000244|PDB:4OEL}.
FT   STRAND      123    128       {ECO:0000244|PDB:4OEL}.
FT   STRAND      133    141       {ECO:0000244|PDB:4OEL}.
FT   STRAND      254    256       {ECO:0000244|PDB:2DJF}.
FT   HELIX       258    274       {ECO:0000244|PDB:4OEL}.
FT   TURN        275    277       {ECO:0000244|PDB:4OEL}.
FT   HELIX       285    291       {ECO:0000244|PDB:4OEL}.
FT   HELIX       297    299       {ECO:0000244|PDB:4OEM}.
FT   HELIX       303    306       {ECO:0000244|PDB:4OEL}.
FT   HELIX       309    313       {ECO:0000244|PDB:4OEL}.
FT   HELIX       319    321       {ECO:0000244|PDB:4OEL}.
FT   STRAND      342    347       {ECO:0000244|PDB:4OEL}.
FT   HELIX       357    367       {ECO:0000244|PDB:4OEL}.
FT   STRAND      370    374       {ECO:0000244|PDB:4OEL}.
FT   HELIX       378    382       {ECO:0000244|PDB:4OEL}.
FT   STRAND      385    388       {ECO:0000244|PDB:4OEL}.
FT   STRAND      405    414       {ECO:0000244|PDB:4OEL}.
FT   TURN        416    418       {ECO:0000244|PDB:4OEL}.
FT   STRAND      421    426       {ECO:0000244|PDB:4OEL}.
FT   STRAND      431    433       {ECO:0000244|PDB:2DJG}.
FT   STRAND      438    442       {ECO:0000244|PDB:4OEL}.
FT   TURN        443    446       {ECO:0000244|PDB:4CDE}.
FT   HELIX       447    449       {ECO:0000244|PDB:4OEL}.
FT   STRAND      455    459       {ECO:0000244|PDB:4OEL}.
SQ   SEQUENCE   463 AA;  51854 MW;  4C9C7C24D900CEE6 CRC64;
     MGAGPSLLLA ALLLLLSGDG AVRCDTPANC TYLDLLGTWV FQVGSSGSQR DVNCSVMGPQ
     EKKVVVYLQK LDTAYDDLGN SGHFTIIYNQ GFEIVLNDYK WFAFFKYKEE GSKVTTYCNE
     TMTGWVHDVL GRNWACFTGK KVGTASENVY VNIAHLKNSQ EKYSNRLYKY DHNFVKAINA
     IQKSWTATTY MEYETLTLGD MIRRSGGHSR KIPRPKPAPL TAEIQQKILH LPTSWDWRNV
     HGINFVSPVR NQASCGSCYS FASMGMLEAR IRILTNNSQT PILSPQEVVS CSQYAQGCEG
     GFPYLIAGKY AQDFGLVEEA CFPYTGTDSP CKMKEDCFRY YSSEYHYVGG FYGGCNEALM
     KLELVHHGPM AVAFEVYDDF LHYKKGIYHH TGLRDPFNPF ELTNHAVLLV GYGTDSASGM
     DYWIVKNSWG TGWGENGYFR IRRGTDECAI ESIAVAATPI PKL
//
